Norway
# |
Name |
EBITDA |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 6.26 M
|
Dec. 31, 2023 | USD 4.95 | -0.09% |
|
Norway |
|
2 |
USD 3.64 M
|
Dec. 31, 2023 | USD 2.17 | -0.37% |
|
Norway |
|
3 |
USD 3.11 M
|
Dec. 31, 2023 | USD 1.20 | -0.29% |
|
Norway |
|
4 |
USD -295.21 K
|
Dec. 31, 2023 | USD 3.46 | 4.14% |
|
Norway |
|
5 |
USD -670.44 K
|
Dec. 31, 2023 | USD 0.22 | 4.62% |
|
Norway |
|
6 |
USD -2.18 M
|
Dec. 31, 2023 | USD 0.11 | -3.45% |
|
Norway |
|
7 |
USD -3.15 M
|
Dec. 31, 2023 | USD 1.36 | 33.77% |
|
Norway |
|
8 |
USD -6.93 M
|
Dec. 31, 2023 | USD 0.17 | -2.50% |
|
Norway |
|
9 |
USD -18.61 M
|
Dec. 31, 2023 | USD 0.77 | -0.80% |
|
Norway |
|
10 |
USD -21.09 M
|
Dec. 31, 2023 | USD 0.19 | 2.37% |
|
Norway |
|
11 |
USD -41.74 M
|
Dec. 31, 2023 | USD 0.23 | 0.44% |
|
Norway |
The Pharmaceuticals company in Norway with the highest EBITDA is Photocure ASA (Oslo Stock Exchange: PHO.OL) at USD 6.26 M.
The Pharmaceuticals company in Norway with the lowest EBITDA is Nykode Therapeutics AS (Oslo Stock Exchange: NYKD.OL) at USD -41.74 M.
The top 10 Pharmaceuticals companies in Norway by EBITDA are Photocure ASA, Navamedic ASA, ArcticZymes Technologies ASA, Gentian Diagnostics ASA, Thor Medical ASA, PCI Biotech Holding ASA, Lifecare AS, Hofseth BioCare ASA, BerGenBio ASA and Ultimovacs ASA.
The bottom 10 Pharmaceuticals companies in Norway by EBITDA are Nykode Therapeutics AS, Ultimovacs ASA, BerGenBio ASA, Hofseth BioCare ASA, Lifecare AS, PCI Biotech Holding ASA, Thor Medical ASA, Gentian Diagnostics ASA, ArcticZymes Technologies ASA and Navamedic ASA.